Mercury Laboratories Ltd Q1FY22 PAT zooms to Rs. 1.24 crore

Mercury Laboratories Limited has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.15.65 crores during the period ended June 30, 2021 as compared to Rs.18.10 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.1.24 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.6869 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.10.38 for the period ended June 30, 2021 as compared to Rs.5.72 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 15.65 crs	₹ 18.10 crs	-13.54%
Net Profit	₹ 1.24 crs	₹ 0.6869 crs	80.52%
EPS	₹ 10.38	₹ 5.72	81.47%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.15.65 crores during the period ended June 30, 2021 as compared to Rs.13.38 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.1.24 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.9607 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.10.38 for the period ended June 30, 2021 as compared to Rs.8.01 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 15.65 crs	₹ 13.38 crs	16.97%
Net Profit	₹ 1.24 crs	₹ 0.9607 crs	29.07%
EPS	₹ 10.38	₹ 8.01	29.59%

Shares of Mercury Laboratories Limited was last trading in BSE at Rs. 715.95 as compared to the previous close of Rs. 715.8. The total number of shares traded during the day was 130 in over 29 trades.

The stock hit an intraday high of Rs. 722.7 and intraday low of 670. The net turnover during the day was Rs. 90873.

Source : Equity Bulls

Keywords